Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Herz
Erschienen in: Herz 1/2014

01.02.2014 | Schwerpunkt

Schlafbezogene Atmungsstörungen und kardiovaskuläre (Folge-)Erkrankungen

verfasst von: PD Dr. O. Oldenburg, T. Bitter, H. Fox, D. Horstkotte

Erschienen in: Herz | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Zusammenfassung

Schlafbezogene Atmungsstörungen kommen bei kardiologischen Patienten meist in Form der obstruktiven (OSA) oder zentralen Schlafapnoe (CSA) mit Cheyne-Stokes-Atmung vor. Die Prävalenzen und Inzidenzen sind gegenüber der Allgemeinbevölkerung deutlich erhöht. Abhängig von der kardiologischen Grunderkrankung können bis zu 75% eine OSA oder CSA aufweisen, bis zu 50% haben eine nach aktuellen Leitlinien bestehende Therapieindikation. Die OSA wird für viele kardiovaskuläre Herzerkrankungen als eigenständiger und gut behandelbarer Risikofaktor für die Entstehung und Verschlechterung angesehen. Beispielhaft beschreibt diese Übersichtsarbeit in Kurzform die Prävalenzen, die Pathophysiolgie und die aktuelle Studienlage zum Zusammenhang von schlafbezogenen Atmungsstörungen und arterieller Hypertonie, Vorhofflimmern, Arteriosklerose mit koronarer Herzerkrankung (KHK) und Myokardinfarkt sowie der Herzinsuffizienz. Während für diese Erkrankungen die Rolle der OSA als Risikofaktor für ihre Entstehung gut belegt ist, wird die CSA weniger als Risikofaktor per se, sondern vielmehr als Ausdruck einer kardialen Grunderkrankung mit dann weiteren negativen Auswirkungen für diese angesehen. Nicht die Schlafapnoe als solche, sondern die kardiovaskulären Folgeerkrankungen limitieren die Prognose dieser Patienten und rücken sie somit in den kardiologischen Fokus. Durch verschiedene nächtliche Beatmungstherapien können OSA und CSA erfolgversprechend und nachhaltig therapiert werden. Darüber hinaus sind weitere Therapieverfahren in der Erprobung; ihre Wertigkeit wird in den kommenden Jahren untersucht werden.
Literatur
1.
2.
Bradley T, Holloway R, McLaughlin P et al (1992) Cardiac output response to continuous positive airway pressure in congestive heart failure. Am Rev Respir Dis 145:377–382PubMed
3.
Bradley T, Hall M, Ando S (2001) Hemodynamic effects of simulated obstructive apneas in humans with and without heart failure. Chest 119:1827–1835PubMed
4.
Bradley T, Tkacova R, Hall M et al (2003) Augmented sympathetic neural response to simulated obstructive apnoea in human heart failure. Clin Science 104:231–238
5.
Becker HF, Ficker J, Fietze I et al (2009) S3-Leitlinie Nicht erholsamer Schlaf/Schlafstörungen. Somnologie – Schlafforschung und Schlafmedizin 13:1–160
6.
Arzt M, Young T, Finn L et al (2006) Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Ann Intern Med 166:1716–1722
7.
Bitter T, Westerheide N, Hossain MS et al (2012) Symptoms of sleep apnoea in chronic heart failure – results from a prospective cohort study in 1,500 patients. Sleep Breath 16:781–791PubMed
8.
Bradley T, Floras J (2003) Sleep apnea and heart failure: part II: central sleep apnea. Circulation 107:1822–1826PubMed
9.
Oldenburg O, Bitter T, Wiemer M et al (2009) Pulmonary capillary wedge pressure and pulmonary artery pressure in heart failure patients with sleep-disordered breathing. Sleep Med 10:726–730PubMed
10.
Oldenburg O (2012) Cheyne-Stokes respiration in chronic heart failure. Treatment by adaptive servoventilation. Circ J 76:2305–2317PubMed
11.
Yumino D, Redolfi S, Ruttanaumpawan P et al (2010) Nocturnal rostal fluid shift. A unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation 121:1598–1605PubMed
12.
Young T, Palta M, Dempsey J et al (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235PubMed
13.
Pankow W, Nabe B, Lies A et al (1997) Influence of sleep apnea on 24-hour blood pressure. Chest 112:1253–1258PubMed
14.
Pedrosa RP, Drager LF, Paula LK de et al (2013) Effects of OSA treatment on BP in patients with resistant hypertension: a randomized trial. Chest 144:1487–1494PubMed
15.
Bitter T, Langer C, Vogt J et al (2009) Schlafbezogene Atemstörungen. Charakteristika bei Vorhofflimmern und erhaltener linksventrikulärer Funktion. Dtsch Arztebl Int 106:164–170PubMedCentralPubMed
16.
Oldenburg O, Lamp B, Faber L et al (2007) Sleep disordered breathing in patients with symptomatic heart failure. Eur J Heart Fail 9:251–257PubMed
17.
Oldenburg O, Faber L, Vogt J et al (2007) Influence of cardiac resynchronisation therapy on different types of sleep disordered breathing. Eur J Heart Fail 9:820–826PubMed
18.
Bitter T, Faber L, Hering D et al (2009) Sleep-disordered breathing in heart failure with normal ejection fraction. Eur J Heart Fail 11:602–608PubMed
19.
Solin P, Bergin P, Richardson M et al (1999) Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 99:1574–1579PubMed
20.
Efken C, Bitter T, Prib N et al (2012) Obstructive sleep apnoea: longer respiratory event lengths in patients with heart failure. Eur Resp J 41:1340–1346
21.
Wedewardt J, Bitter T, Prinz C et al (2010) Cheyne-Stokes respiration in heart failure: cycle length is dependent on left ventricular ejection fraction. Sleep Med 11:137–142PubMed
22.
Argod J, Pépin JL, Lévy P (1998) Differentiating obstructive and central sleep respiratory events through pulse transit time. Am J Respir Crit Care Med 158:1778–1783PubMed
23.
Defaye P, Pépin JL, Poezevara Y et al (2004) Automatic recognition of abnormal respiratory events during sleep by a pacemaker transthoracic impedance sensor. J Cardiovasc Electrophysiol 15:1034–1040PubMed
24.
Dingli K, Coleman E, Vennelle M et al (2003) Evaluation of a portable device for diagnosing the sleep apnoea/hypopnoea syndrome. Eur Respir J 21:253–259PubMed
25.
Freimark D, Adler Y, Sheffy J et al (2002) Oscillations in peripheral arterial tone in congestive heart failure patiens: a new marker for Cheyne-Stokes breathing. Cardiology 98:21–24PubMed
26.
Garcia-Diaz E, Quintana-Gallego E, Ruiz A et al (2007) Respiratory polygraphy with actigraphy in the diagnosis of sleep apnea-hypopnea syndrome. Chest 31:725–732
27.
Golpe R, Jimenez A, Carpizo R (2002) Home sleep studies in the assessment of sleep apnea/hypopnea syndrome. Chest 122:1156–1161PubMed
28.
Nigro C, Dibur E, Malnis S et al (2013) Validation of ApneaLink Ox for the diagnosis of obstructive sleep apnea. Sleep Breath 17:258–266
29.
Quintana-Gallego E, Villa-Gil M, Carmona-Bernal C et al (2004) Home respiratory polygraphy for diagnosis of sleep-disordered breathing in heart failure. Eur Respir J 24:443–448PubMed
30.
Stevenson I, Cunnington D, Teichtahl H, Mond H (2006) Pacemaker diagnosis of sleep disordered breathing. Pacing Clin Electrophysiol 29:1033–1035PubMed
31.
Vazir A, Dayer M, Hastings P et al (2006) Can heart rate variation rule out sleep-disordered breathing in heart failure? Eur Respir J 27:571–577PubMed
32.
Weinreich G, Armitstead J, Töpfer V et al (2009) Validation of ApneaLink as screening device for Cheyne-Stokes respiration. Sleep 32:555–557
33.
Bundesausschuss der Ärzte und Krankenkassen (2005) Richtlinie zur Bewertung medizinischer Untersuchungs- und Behandlungsmethoden (BUB-Richtlinie). Bundesanzeiger Nr. 90 (S 7485)
34.
Gami AS, Olson EJ, Shen WK et al (2013) Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults. J Am Coll Cardiol 62:610–616PubMed
35.
Gami A, Pressman G, Caples S et al (2004) Association of atrial fibrillation and obstructive sleep apnea. Circulation 110:364–367PubMed
36.
Gami A, Howard D, Olson E, Somers V (2005) Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 352:1206–1214PubMed
37.
Gami A, Hodge D, Herges R et al (2007) Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 49:565–571PubMed
38.
Gami A, Rader S, Svatikova A et al (2007) Familial premature coronary artery disease mortality and obstructive sleep apnea. Chest 131:118–121PubMed
39.
Gottlieb D, Yenokyan G, Newman A et al (2010) Prospective study of obstructive sleep apnea and incident of coronary heart disease and heart failure. The Sleep Heart Health Study. Circulation 122:352–360PubMedCentralPubMed
40.
Guilleminault C, Connolly SJ, Winkle RA (1983) Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 52:490–494PubMed
41.
Javaheri S, Caref E, Chen E et al (2010) Sleep apnea testing and outcomes in a large cohort of medicare beneficiaries with newly diagnosed heart failure. Am J Respir Crit Care Med 183:539–546PubMed
42.
Koshino Y, Satoh M, Katayose Y et al (2008) Association of sleep-disordered breathing and ventricular arrhythmias in patients without heart failure. Am J Cardiol 101:882–886PubMed
43.
Levy P, Ryan S, Oldenburg O, Parati G (2013) Sleep apnoea and the heart. Eur Respir Rev 22:333–352PubMed
44.
Lindberg E, Taube A, Janson C et al (1998) A 10-year follow-up of snoring in men. Chest 114:1048–1055PubMed
45.
Peker Y, Hedner J, Norum J et al (2002) Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea. Am J Respir Crit Care Med 166:159–165PubMed
46.
Peker Y, Carlson J, Hedner J (2006) Increased incidence of coronary artery disease in sleep apnea: a long-term follow-up. Eur Respir J 28:596–602PubMed
47.
Prinz C, Bitter T, Piper C et al (2010) Sleep apnea is common in patients with coronary artery disease. Wien Med Wochenschr 160:349–355PubMed
48.
Shahar E, Whitney C, Redline S et al (2001) Sleep-disordered breathing and cardiovascular disease. Cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163:19–25PubMed
49.
Wang TJ, Evans JC, Benjamin EJ et al (2003) Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 108:977–982PubMed
50.
Young T, Peppard P, Palta M et al (1997) Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Int Med 157:1746–1752
51.
Marin J, Agusti A, Villar I et al (2012) Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA 307:2169–2176PubMed
52.
Guillot M, Sforza E, Achour-Crawford E et al (2013) Association between severe obstructive sleep apnea and incident arterial hypertension in the older people population. Sleep Med 14(9):838–842PubMed
53.
Peppard P, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342:1378–1384PubMed
54.
Barbe M, Duran-Cantolla J, Sanchez-de-la-Torre M et al (2012) Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA 307:2161–2168PubMed
55.
Barbe F, Duran-Cantolla J, Capote F et al (2010) Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 181:718–726PubMed
56.
Becker HF, Jerrentrup A, Ploch T et al (2003) Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107:68–73PubMed
57.
Kasiakogias A, Tsioufis C, Thomopoulos C et al (2013) Effects of continuous positive airway pressure on blood pressure in hypertensive patients with obstructive sleep apnea: a 3-year follow-up. J Hypertens 31:352–360PubMed
58.
Pepin J, Tamisier R, Barone-Rochette G et al (2010) Comparison of continuous positive airway pressure and valsartan in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 182:954–960PubMed
59.
Fava C, Dorigoni S, Dalle Vedove F et al (2013) Effect of continuous positive airway pressure (CPAP) on blood pressure in patients with obstructive sleep apnea/hypopnea. A systematic review and meta-analysis. Chest [Epub ahead of print]
60.
Chobanian AV, Bakris GL, Black HR (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289:2560–2571PubMed
61.
Parati G, Lombardi C, Hedner J et al (2012) Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (COoperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea. J Hypertens 30:633–646PubMed
62.
Parati G, Lombardi C, Hedner J et al (2013) Recommendations for the management of patients with obstructive sleep apnoea and hypertension. Eur Respir J 41:523–538PubMed
63.
Somers V, White D, Amin R et al (2008) Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation scientific statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 52:686–717PubMed
64.
Podszus T, Seevers H, Mayer G, Baumann G (2009) Positionspapier „Schlafmedizin in der Kardiologie“. Kardiologe 3:9–15
65.
Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens 31:1281–1357PubMed
66.
Mehra R, Benjamin E, Shahar E et al (2006) Association of nocturnal arrhyhmias with sleep-disordered breathing. Am J Respir Crit Care Med 173:910–916PubMedCentralPubMed
67.
Lissel C, Hennigs S, Hoffmann-Castendiek B et al (2008) Effects of restoring sinus rhythm on sleep apnea in patients with atrial fibrillation or flutter. Am J Cardiol 102:709–711PubMed
68.
Naruse Y, Tada H, Satoh M et al (2011) Radiofrequency catheter ablation for persistent atrial fibrillation improves sleep-disordered breathing. Heart Rhythm 8(Suppl):S266
69.
Kanagala R, Murali N, Friedman P et al (2003) Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 107:2589–2594PubMed
70.
Bitter T, Nölker G, Vogt J et al (2012) Predictors of recurrence in patients undergoing cryoballoon ablation for treatment of atrial fibrillatrion: the independent role of sleep-disordered breathing. J Cardiovasc Electrophysiol 23:18–25PubMed
71.
Matiello M, Nadal M, Tamborero D et al (2010) Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients. Europace 12:1084–1089PubMed
72.
Naruse Y, Tada H, Satoh M et al (2013) Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy. Heart Rhythm 10:331–337PubMed
73.
Ng CY, Liu T, Shehata M et al (2011) Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am J Cardiol 108:47–51PubMed
74.
Calkins H, Kuck KH, Cappato R et al (2012) 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm 9:632–696PubMed
75.
Leung R, Huber M, Rogge T et al (2005) Association between atrial fibrillation and central sleep apnea. Sleep 28:1542–1546
76.
Jelic S, Padeletti M, Kawut M et al (2008) Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 117:2270–2278PubMedCentralPubMed
77.
Jelic S, Lederer D, Adams T et al (2010) Vascular inflammation in obesity and sleep apnea. Circulation 121:1014–1021PubMedCentralPubMed
78.
Schmalgemeier H, Bitter T, Fischbach T et al (2013) C-Reactive protein is elevated in heart failure patients with central sleep apnea and Cheyne-Stokes respiration. Respiration [Epub ahead of print]
79.
Shamsuzzaman ASM, Winnicki M, Lanfranchi P et al (2002) Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105:2462–2464PubMed
80.
Punjabi NM, Newman AB, Young TB et al (2008) Sleep-disordered breathing and cardiovascular disease. Am J Respir Crit Care Med 177:1150–1155PubMedCentralPubMed
81.
Roca GQ, Redline S, Punjabi N et al (2013) Sleep apnea is associated with subclinical myocardial injury in the community: the ARIC-SHHS study. Am J Respir Crit Care Med 188:1460–1465
82.
Marin J, Carrizo S, Vicente E, Agusti A (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046–1053PubMed
83.
Känel R von, Dimsdale J (2003) Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease. Chest 124:1956–1967
84.
Känel R von, Loredo J, Ancoli-Israel S et al (2007) Association between polysomnographic measures of disrupted sleep and prothrombotic factors. Chest 131:733–739
85.
Känel R von, Natarajan L, Ancoli-Israel S et al (2010) Day/night rhythm of hemostatic factors in obstructive sleep apnea. Sleep 33:371–377
86.
Yumino D, Tsurumi Y, Takagi A et al (2007) Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol 99:26–30PubMed
87.
Cassar A, Morgenthaler T, Lennon R et al (2007) Treatment of obstructive sleep apnea is associated with decreased cardiac death after percutaneous coronary intervention. J Am Coll Cardiol 50:1310–1314PubMed
88.
Jilek C, Krenn M, Sebah D et al (2010) Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study. Eur J Heart Fail 13:68–75PubMed
89.
Damy T, Margarit L, Noroc A et al (2012) Prognostic impact of sleep-disordered breathing and its treatment with nocturnal ventilation for chronic heart failure. Eur J Heart Fail 14:1009–1019PubMed
90.
Wang H, Parker J, Newton G et al (2007) Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 49:1625–1631PubMed
91.
Andreas S, Hagenah G, Möller C et al (1996) Cheyne-Stokes respiration and prognosis in congestive heart failure. Am J Cardiol 78:1260–1264PubMed
92.
Hanly P, Zuberi-Khokhar N (1996) Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med 153:272–276PubMed
93.
Javaheri S, Shukla R, Zeigler H, Wexler L (2007) Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol 49:2028–2034PubMed
94.
Lanfranchi P, Braghiroli A, Bosimini E et al (1999) Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 99:1435–1440PubMed
95.
Luo Q, Zhang HL, Tao XC et al (2010) Impact of untreated sleep apnea on prognosis of patients with congestive heart failure. Int J Cardiol 144:420–422PubMed
96.
Roebuck T, Solin P, Kaye D et al (2004) Increased long-term mortality in heart failure due to sleep apnoea is not yet proven. Eur Respir J 23:735–740PubMed
97.
Sin D, Fitzgerald F, Parker J et al (1999) Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160:1101–1106PubMed
98.
Alonso-Fernández A, García-Río F, Arias MA et al (2006) Obstructive sleep apnea-hypopnea syndrome reversibly depresses cardiac response to exercise. Eur Heart J 27:207–215PubMed
99.
Egea C, Aizpuru F, Pinto J et al (2008) Cardiac function after CPAP therapy in patients with chronic heart failure and sleep apnea: a multicenter study. Sleep Med 9:660–666PubMed
100.
Kasai T, Narui K, Dohi T et al (2008) Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. Chest 133:690–696PubMed
101.
Mansfield D, Gollogly N, Kaye D et al (2004) Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 169:361–366PubMed
102.
Oldenburg O, Horstkotte D (2010) Respiratory instability in patients with chronic heart failure. J Am Coll Cardiol 56:1838–1839PubMed
103.
Oldenburg O, Bitter T, Lehmann R et al (2011) Adaptive servoventilation improves cardiac function and respiratory stability. Clin Res Cardiol 2100:107–115
104.
Teschler H, Döhring J, Wang Y-M, Berthon-Jones M (2001) Adaptive pressure support servo-ventilation. A novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 164:614–619PubMed
105.
Bitter T, Westerheide N, Faber L et al (2010) Adaptive servoventilation in diastolic heart failure and Cheyne-Stokes respiration. Eur Respir J 36:385–392PubMed
106.
Oldenburg O, Bitter T, Wellmann B et al (2013) Trilevel adaptive servoventilation for treatment of central and mixed sleep apnea in chronic heart failure patients. Sleep Med 14:422–427PubMed
107.
Pepperell J, Maskell N, Jones D et al (2003) A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med 168:1109–1114PubMed
108.
Philippe C, Stoica-Herman M, Drouot X et al (2006) Compliance with and efficacy of adaptive servo-ventilation (ASV) versus continuous positive airway pressure (CPAP) in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart 92:337–342PubMedCentralPubMed
109.
Aurora R, Chowdhuri S, Ramar K et al (2012) The treatment of central sleep apnea syndromes in adults: practice parameters with an evdence-based literature review and meta-analysis. Sleep 35:17–40PubMedCentralPubMed
110.
Sharma B, Bakker J, McSharry D et al (2012) Adaptive-servoventilation for treatment of sleep-disordered breathing in heart failure: a systematic review and meta-analysis. Chest 142:1211–1221PubMedCentralPubMed
111.
Koyama T, Watanabe H, Igarashi G et al (2011) Short-term prognosis of adaptive servo-ventilation therapy in patients with heart failure. Circulation J 75:710–712
112.
Yoshihisa A, Shimizu T, Owada T et al (2011) Adaptive servo ventilation improves cardiac dysfunction and prognosis in chronic heart failure patients with Cheyne-Stokes respiration. Int Heart J 52:218–223PubMed
113.
Cowie MR, Woehrle H, Wegscheider K et al (2013) Rationale and design of the SERVE-HF study: treatment of sleep-disordered breathing with predominant central sleep apnoea with adaptive servo-ventilation in patients with chronic heart failure. Eur J Heart Fail 15:1082–1094
Metadaten
Titel
Schlafbezogene Atmungsstörungen und kardiovaskuläre (Folge-)Erkrankungen
verfasst von
PD Dr. O. Oldenburg
T. Bitter
H. Fox
D. Horstkotte
Publikationsdatum
01.02.2014
Verlag
Urban & Vogel
Erschienen in
Herz / Ausgabe 1/2014
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-013-4050-5

Weitere Artikel der Ausgabe 1/2014

Herz 1/2014 Zur Ausgabe

Aktuelle Kardiologie

Aktuelle Kardiologie

Schwerpunkt

Herzchirurgie bei pulmonalen Grunderkrankungen

Retraction Note

Retraction Note - Role of intravascular ultrasound imaging in identifying vulnerable plaques

Schwerpunkt

Lungentransplantation

Case study

Jugular venous congestion in acute pulmonary embolism

e-Herz: Case study

A serious cause of syncope in a young patient

Neu im Fachgebiet Kardiologie

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise